UK patient recruited for thyroid eye disease trial

Published on May 1, 2025
A Frimley Health NHS Foundation Trust patient will receive a weekly injection of Efgartigimod as part of the ARGX-113-2301 trial
Continue reading on website
Other news

ASCRS 2025: Recognizing and managing neurotrophic keratitis with cryopreserved amniotic membrane

April 30, 2025
An emerging treatment approach for a commonly underdiagnosed ocular surface disease.

A closer look at periorbital allergic dermatitis

May 1, 2025
Identifying allergens or irritants can be challenging, but a few strategies can help patients find relief.